Bayesian Population Pharmacokinetic Modeling of Eltrombopag in Chronic Hepatitis C Patients
ConclusionsEltrombopag pharmacokinetic behavior was described using population bayesian approach. This model can be applied to optimize eltrombopag dosing in order to reduce the incidence of thrombocytopenia in HCV-infected patient receiving interferon-based therapy.
Source: European Journal of Drug Metabolism and Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research
More News: Bilirubin | Drugs & Pharmacology | Hepatitis | Hepatitis C | Statistics | Study | Thrombocytopenia